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Stem Cell Research (2015) 14, 131One final word…“Stem cells have captivated the imagination, hopes and
dreams of the world.” It is seven years since I wrote this
sentence to open the editorial for the inaugural issue of
Stem Cell Research and the statement is even more true
today than it was then. Over this period we have witnessed
amazing progress in the field, spanning the dissection of
pluripotency to the sophistication of stem cell differentia-
tion protocols to the initiation of clinical trials with
differentiated stem cells. Perhaps the most wondrous
revelations relate to cellular reprogramming, for which
John Gurdon and Shinya Yamanaka were awarded the Nobel
Prize in 2012, and to the facile and efficient genome
modification now possible through the CRISPR-associated
RNA-guided endonuclease Cas9. These seminal advances
have brought the promise of disease modeling, mutation
correction and the discovery of new drug and cellular
therapies for disease from somewhere in the nebulous future
to the present day.
It has been my absolute privilege to be a part of Stem Cell
Research as the Editor-in-Chief and, of course, to remain a
participating scientist in the field. I have watched anxiously
as the new journal successfully passed the significant
milestones of PubMed listing and the awarding of an impact
factor by Thomson Reuters to become a part of the publishing
landscape in stem cells.
I have had the good fortune to be assisted by a cohort of
wonderful editors over the years. Christine Mummery, Markus
Grompe and Paul Simmonswere the original editorswithwhom
I shared the weekly anxiety of whether we would have enough
high quality papers to publish the next issue. As Christine
and Paul moved on and the journal workload increased, we
recruited Pam Robey, Paolo Bianco, Paul Gadue and Kyle
Orwig. These outstanding scientists have worked diligently for
the journal to publish the best papers possible and I thank
them all for their hard work and for the personal support and
friendship they have provided me. I thank and acknowledge
the wisdom, advice and persistence of my friend Markus
Grompe who has stayed the distance with me!
The journal has been well served by great journal
publishers and managers from Elsevier. I thank the journal
managers Amy Shapiro, Joslyn Paguio, Susan Ikeda and Ninahttp://dx.doi.org/10.1016/j.scr.2014.12.006
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(http://creativecommons.org/licenses/by-nc-nd/4.0/).Biuso who have ably, patiently and good-naturedly assisted
me and the other editors. I thank Noelle Gracy and Steve
Watson who convinced me in 2006 that a new journal
covering stem cells was a good idea (!) and Simone Groothius
who has continued as journal publisher over the past few
years. I thank all these people for their professionalism,
their enthusiasm and their friendship.
The journal owes a great debt to the members of the
editorial board, to the reviewers and to all the authors who
entrusted their precious manuscripts to us. I have always
wanted Stem Cell Research to establish a reputation as a
journal that would help authors to publish their work
through good counsel and constructive criticism. I hope
that we have at least been partly successful in this aim and
that it continues to be the case.
But now, it is time for the journal to be led by someone
with new, fresh ideas and enthusiasm. I could wish for no one
better to fill this role than Thomas Zwaka, recently
appointed as a member of the Senior Faculty at the Icahn
School of Medicine at Mount Sinai in New York. Thomas
comes to this role with a wonderful pedigree as an MD PhD
graduate from the University of Ulm, which led to
post-doctoral training with James Thomson at the University
of Wisconsin prior to establishing his own laboratory at
the Baylor College of Medicine in Texas. I am sure that the
appointment of Thomas Zwaka as Editor-in-Chief, with the
support of Pam Robey as Deputy Editor-in-Chief and the
Associate Editors, will be a great success. I wish them all
well!
So all that remains for me is to say ‘goodbye’ and to quote
from Douglas Adams, So Long, and Thanks for All the Fish"
(look it up if you are not familiar with The Hitchhiker's Guide
to the Galaxy)!
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